Magnetic Resonance Imaging of Rectal Cancer

Abstract

High-resolution magnetic resonance imaging (MRI) plays a pivotal role in the pretreatment assessment of primary rectal cancer. The success of this technique depends on obtaining good-quality high-resolution T2-weighted images of the primary tumor, orthogonal to rectal lumen. The goal of magnetic resonance staging is to identify patients who will benefit from neoadjuvant therapy prior to surgery to minimize postoperative recurrence and planning of optimal surgical approach. MRI also facilitates optimal identification of important prognostic factors, which improves both treatment selection and posttreatment follow-up. The objective of this article is to review the existing literature and provide a concise update on various aspects of rectal cancer imaging, discuss the current role of advanced imaging techniques such as diffusion-weighted and perfusion imaging in the evaluation of rectal cancer, and to assess response to therapy.

Keywords

magnetic resonance imaging - rectal cancer - preoperative staging - treatment response

• References

• 1 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63 (01) 11-30
• 2 American Cancer Society. Colorectal Cancer Facts and Figures 2011–2013. Atlanta, GA: American Cancer Society; 2011
• 3 Sauer R, Becker H, Hohenberger W. et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351 (17) 1731-1740
• 4 Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133 (08) 894-899
• 5 Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI staging of low rectal cancer. Eur Radiol 2009; 19 (03) 643-650
• 6 Kosinski L, Habr-Gama A, Ludwig K, Perez R. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin 2012; 62 (03) 173-202
• 7 Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005; 9 (03) 193-199 discussion 199–200
• 8 Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2 8514 996-999
• 9 Liu Q, Luo D, Cai S, Li Q, Li X. Circumferential resection margin as a prognostic factor after rectal cancer surgery: a large population-based retrospective study. Cancer Med 2018; 7 (08) 3673-3681 [Epub ahead of print]
• 10 Furey E, Jhaveri KS. Magnetic resonance imaging in rectal cancer. Magn Reson Imaging Clin N Am 2014; 22 (02) 165-190 v–vi
• 11 User's Guide for the synoptic MRI report for Pre-operative staging of Rectal Cancer 2015, 1–25. A joint initiative of Cancer Care Ontario and the Canadian Cancer Society. https://archive.cancer-care.on.ca
• 12 Garcia-Aguilar J, Pollack J, Lee SH. et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002; 45 (01) 10-15
• 13 Halefoglu AM, Yildirim S, Avlanmis O, Sakiz D, Baykan A. Endorectal ultrasonography versus phased-array magnetic resonance imaging for preoperative staging of rectal cancer. World J Gastroenterol 2008; 14 (22) 3504-3510
• 14 Puli SR, Bechtold ML, Reddy JBK, Choudhary A, Antillon MR, Brugge WR. How good is endoscopic ultrasound in differentiating various T stages of rectal cancer?. Meta-analysis and systematic review. Ann Surg Oncol 2009; 16 (02) 254-265
• 15 Bipat S, Glas AS, Slors FJM, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging—a meta-analysis. Radiology 2004; 232 (03) 773-783
• 16 Beaumont C, Pandey T, Gaines Fricke R, Laryea J, Jambhekar K. MR evaluation of rectal cancer: current concepts. Curr Probl Diagn Radiol 2013; 42 (03) 99-112
• 17 Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004; 232 (02) 335-346
• 18 Maizlin ZV, Brown JA, So G. et al. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?. Dis Colon Rectum 2010; 53 (03) 308-314
• 19 Eglinton T, Luck A, Bartholomeusz D, Varghese R, Lawrence M. Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer. Colorectal Dis 2010; 12 (07) 667-673
• 20 Balyasnikova S, Brown G. Optimal imaging strategies for rectal cancer staging and ongoing management. Curr Treat Options Oncol 2016; 17 (06) 32
• 21 Gollub MJ, Arya S, Beets-Tan RG. et al. Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY) 2018; 43 (11) 2893-2902
• 22 Slater A, Halligan S, Taylor SA, Marshall M. Distance between the rectal wall and mesorectal fascia measured by MRI: Effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol 2006; 61 (01) 65-70
• 23 Kaur H, Choi H, You YN. et al. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 2012; 32 (02) 389-409
• 24 Dewhurst C, Rosen MP, Blake MA. et al. ACR Appropriateness Criteria pretreatment staging of colorectal cancer. J Am Coll Radiol 2012; 9 (11) 775-781
• 25 Brown G, Daniels IR. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Res 2005; 165: 58-74
• 26 Torkzad MR, Påhlman L, Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging 2010; 1 (04) 245-267
• 27 MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007; 243 (01) 132-139
• 28 Suzuki C, Torkzad MR, Tanaka S. et al. The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol 2008; 6: 89
• 29 Kim H, Lim JS, Choi JY. et al. Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging. Radiology 2010; 254 (02) 485-492
• 30 Jao SY, Yang BY, Weng H, Yeh CH, Lee LW. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Colorectal Dis 2010; 12 (11) 1139-1148
• 31 Gollub MJ, Lakhman Y, McGinty K. et al. Does gadolinium-based contrast material improve diagnostic accuracy of local invasion in rectal cancer MRI?. A multireader study. AJR Am J Roentgenol 2015; 204 (02) W160-7
• 32 Vliegen RF, Beets GL, von Meyenfeldt MF. et al. Rectal cancer: MR imaging in local staging—is gadolinium-based contrast material helpful?. Radiology 2005; 234 (01) 179-188
• 33 Beets-Tan RGH, Lambregts DMJ, Maas M. et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018; 28 (04) 1465-1475
• 34 Dijkhoff RAP, Beets-Tan RGH, Lambregts DMJ, Beets GL, Maas M. Value of DCE-MRI for staging and response evaluation in rectal cancer: a systematic review. Eur J Radiol 2017; 95: 155-168
• 35 Lim KS, Tan CH. Diffusion-weighted MRI of adult male pelvic cancers. Clin Radiol 2012; 67 (09) 899-908
• 36 Mizukami Y, Ueda S, Mizumoto A. et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg 2011; 35 (04) 895-899
• 37 Rudisch A, Kremser C, Judmaier W, Zunterer H, DeVries AF. Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. Eur J Radiol 2005; 53 (03) 514-519
• 38 Dujovny N, Quiros RM, Saclarides TJ. Anorectal anatomy and embryology. Surg Oncol Clin N Am 2004; 13 (02) 277-293
• 39 Gollub MJ, Maas M, Weiser M. et al. Recognition of the anterior peritoneal reflection at rectal MRI. AJR Am J Roentgenol 2013; 200 (01) 97-101
• 40 Brown G, Kirkham A, Williams GT. et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 2004; 182 (02) 431-439
• 41 Salerno G, Daniels IR, Moran BJ, Wotherspoon A, Brown G. Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience. Clin Radiol 2006; 61 (11) 916-923
• 42 Bhoday J, Balyasnikova S, Wale A, Brown G. How should imaging direct/orient management of rectal cancer?. Clin Colon Rectal Surg 2017; 30 (05) 297-312
• 43 American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed.. New York, NY: Springer; 2010
• 44 Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol 2008; 191 (06) 1827-1835
• 45 Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90 (03) 355-364
• 46 Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004; 54 (06) 295-308
• 47 Taylor FG, Quirke P, Heald RJ. et al; MERCURY study group. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 2011; 98 (06) 872-879
• 48 Jhaveri KS, Hosseini-Nik H. MRI of rectal cancer: an overview and update on recent advances. AJR Am J Roentgenol 2015; 205 (01) W42-55
• 49 Beets-Tan RG, Beets GL, Vliegen RF. et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357 (9255) 497-504
• 50 Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001; 16 (05) 298-304
• 51 Pollheimer MJ, Kornprat P, Pollheimer VS. et al. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis 2010; 25 (02) 187-196
• 52 Brown G, Richards CJ, Newcombe RG. et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999; 211 (01) 215-222
• 53 Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95 (02) 229-236
• 54 Cho MS, Park YY, Yoon J. et al. MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery. J Surg Oncol 2018; 117 (08) 1823-1832
• 55 Park IJ, Kim JC. Adequate length of the distal resection margin in rectal cancer: from the oncological point of view. J Gastrointest Surg 2010; 14 (08) 1331-1337
• 56 Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence?. A systematic review. Ann Surg Oncol 2012; 19 (03) 801-808
• 57 Engelen SM, Beets-Tan RG, Lahaye MJ, Kessels AG, Beets GL. Location of involved mesorectal and extramesorectal lymph nodes in patients with primary rectal cancer: preoperative assessment with MR imaging. Eur J Surg Oncol 2008; 34 (07) 776-781
• 58 Wang C, Zhou ZG, Yu YY. et al. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer. Eur J Surg Oncol 2007; 33 (04) 463-467
• 59 Luna-Pérez P, Corral P, Labastida S, Rodríguez-Coria D, Delgado S. Inguinal lymph node metastases from rectal adenocarcinoma. J Surg Oncol 1999; 70 (03) 177-180
• 60 Schaap DP, Ogura A, Nederend J. et al. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer. Br J Surg 2018; 105 (13) 1844-1852 [Epub ahead of print]
• 61 Brown G, Richards CJ, Bourne MW. et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227 (02) 371-377
• 62 Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol 2004; 52 (01) 78-83
• 63 Matsuoka H, Nakamura A, Sugiyama M, Hachiya J, Atomi Y, Masaki T. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. what is the optimal criterion?. Anticancer Res 2004; 24 (06) 4097-4101
• 64 Mir N, Sohaib SA, Collins D, Koh DM. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol 2010; 54 (04) 358-364
• 65 Will O, Purkayastha S, Chan C. et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006; 7 (01) 52-60
• 66 Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for Ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 2015; 41 (04) 884-898
• 67 Lambregts DM, Beets GL, Maas M. et al. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 2011; 253 (03) 539-545
• 68 Lambregts DM, Heijnen LA, Maas M. et al. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging 2013; 38 (04) 720-727
• 69 Heijnen LA, Lambregts DM, Martens MH. et al. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?. Eur Radiol 2014; 24 (02) 371-379
• 70 Kantorová I, Lipská L, Bêlohlávek O, Visokai V, Trubaĉ M, Schneiderová M. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003; 44 (11) 1784-1788
• 71 Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol 2008; 38 (05) 347-353
• 72 Koh DM, Brown G, Husband JE. Nodal staging in rectal cancer. Abdom Imaging 2006; 31 (06) 652-659
• 73 Kim DJ, Kim JH, Ryu YH, Jeon TJ, Yu JS, Chung JJ. Nodal staging of rectal cancer: high-resolution pelvic MRI versus 18F-FDG-PET/CT. J Comput Assist Tomogr 2011; 35 (05) 531-534
• 74 Roh MS, Colangelo LH, O'Connell MJ. et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27 (31) 5124-5130
• 75 Patel UB, Blomqvist LK, Taylor F. et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response—the MERCURY experience. AJR Am J Roentgenol 2012; 199 (04) W486-95
• 76 Chand M, Swift RI, Tekkis PP, Chau I, Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 2014; 110 (01) 19-25
• 77 Del Vescovo R, Trodella LE, Sansoni I. et al. MR imaging of rectal cancer before and after chemoradiation therapy. Radiol Med (Torino) 2012; 117 (07) 1125-1138
• 78 Hussain SM, Outwater EK, Siegelman ES. Mucinous versus nonmucinous rectal carcinomas: differentiation with MR imaging. Radiology 1999; 213 (01) 79-85
• 79 Petrillo A, Fusco R, Petrillo M. et al. Dynamic contrast enhanced MRI in locally advanced rectal cancer: value of time intensity curve visual inspection to assess neo-adjuvant therapy response. J. Physiol. Health 2014; 110: 255-267
• 80 Jung SH, Heo SH, Kim JW. et al. Predicting response to neo-adjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging 2012; 35 (01) 110-116
• 81 van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 2013; 269 (01) 101-112
• 82 Enkhbaatar NE, Inoue S, Yamamuro H. et al. MR Imaging with Apparent diffusion coefficient histogram analysis: evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy. Radiology 2018; 288 (01) 129-137
• 83 Sun YS, Zhang XP, Tang L. et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254 (01) 170-178
• 84 DeVries AF, Kremser C, Hein PA. et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56 (04) 958-965
• 85 Quaia E, Gennari AG, Ricciardi MC, Ulcigrai V, Angileri R, Cova MA. Value of percent change in tumoral volume measured at T2-weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma. J Magn Reson Imaging 2016; 44 (06) 1415-1424
• 86 Birlik B, Obuz F, Elibol FD. et al. Diffusion-weighted MRI and MR-volumetry—in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging 2015; 33 (02) 201-212
• 87 Horvat N, Veeraraghavan H, Khan M. et al. MR Imaging of rectal cancer: Radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology 2018; 287 (03) 833-843
• 88 Lambrecht M, Vandecaveye V, De Keyzer F. et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2012; 82 (02) 863-870
• 89 Lambregts DMJ, Yassien AB, Lahaye MJ. et al. Monitoring early changes in rectal tumor morphology and volume during 5 weeks of preoperative chemoradiotherapy - An evaluation with sequential MRIs. Radiother Oncol 2018; 126 (03) 431-436
• 90 Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12 (01) 19-23
• 91 Aker M, Boone D, Chandramohan A, Sizer B, Motson R, Arulampalam T. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Abdom Radiol (NY) 2018; 43: 3213